Literature DB >> 9376193

Antiproliferative effects of paclitaxel (Taxol) on human renal clear cell carcinomas in vitro.

P Reinecke1, J Corvin, H E Gabbert, C D Gerharz.   

Abstract

The aim of this study was to analyse the direct antiproliferative effects of paclitaxel on 20 different renal clear cell carcinoma (RCCC) cell lines comparing the effects of paclitaxel dissolved in either DMSO or Cremophor EL/ethanol (Taxol). The MTT assay was used to determine the growth inhibition of the cell lines by paclitaxel. In addition, micronuclei and microtubule alterations were examined by light and immunofluorescence microscopy. A significant (P < 0.05) dose-dependent inhibition of proliferation was evident in 19 out of 20 cell lines after exposure to paclitaxel dissolved in DMSO and in all cell lines after exposure to paclitaxel in Cremophor EL/ethanol. The extent of response markedly varied between the different cell lines ranging from modest effects to reduction of cell viability down to 1-2% of the control. The effects of paclitaxel in Cremophor EL/ethanol proved to be more pronounced than the effects of paclitaxel dissolved in DMSO. This observation could be explained by additional growth inhibitory effects of Cremophor EL alone. Light microscopy revealed extensive micronucleus formation after treatment with paclitaxel. However, the failure to demonstrate differences of micronucleus formation in paclitaxel-responsive and non-responsive RCCC cell lines argued against a causal relationship between micronucleus formation and growth inhibition. Immunofluorescence microscopy revealed no differences in the formation of abnormal microtubules in cell lines responsive or non-responsive to the growth inhibitory effects of paclitaxel. Further investigations, therefore, are needed to understand the mechanisms determining the response of RCCCs to paclitaxel treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376193     DOI: 10.1016/s0959-8049(97)00069-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

2.  A novel method for analyzing mitochondrial movement: inhibition by paclitaxel in a pheochromocytoma cell model.

Authors:  Tal Shprung; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-18       Impact factor: 3.444

3.  Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma.

Authors:  Hervé Lang; Claire Béraud; Audrey Bethry; Sabrina Danilin; Véronique Lindner; Catherine Coquard; Sylvie Rothhut; Thierry Massfelder
Journal:  Oncotarget       Date:  2016-09-13

4.  CGAS is a micronucleophagy receptor for the clearance of micronuclei.

Authors:  Mengmeng Zhao; Fei Wang; Juehui Wu; Yuanna Cheng; Yajuan Cao; Xiangyang Wu; Mingtong Ma; Fen Tang; Zhi Liu; Haipeng Liu; Baoxue Ge
Journal:  Autophagy       Date:  2021-03-22       Impact factor: 16.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.